Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human embryonic stem cells possess immune-privileged properties.

Li Li1, Miren L Baroja, Anish Majumdar

  • 1Robarts Research Institute, Krembil Centre for Stem Cell Biology and Regenerative Medicine, 100 Perth Drive, London, Ontario, Canada, N6A5K8.

Stem Cells (Dayton, Ohio)
|July 28, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scaling up polarized RPE cell supernatant production on parylene membrane.

Experimental eye research·2024
Same author

The induction of SHP-1 degradation by TAOK3 ensures the responsiveness of T cells to TCR stimulation.

Science signaling·2024
Same author

Polarized RPE Secretome Preserves Photoreceptors in Retinal Dystrophic RCS Rats.

Cells·2023
Same author

NOD2 Agonism Counter-Regulates Human Type 2 T Cell Functions in Peripheral Blood Mononuclear Cell Cultures: Implications for Atopic Dermatitis.

Biomolecules·2023
Same author

Development of a Surgical Technique for Subretinal Implants in Rats.

Journal of visualized experiments : JoVE·2022
Same author

Flow Cytometric Characterization of Pluripotent Cell Protein Markers in Naïve, Formative, and Primed Pluripotent Stem Cells.

Methods in molecular biology (Clifton, N.J.)·2022

Human embryonic stem cells (hESCs) exhibit unique immune-privileged properties, showing no immune response in mice and inhibiting T-cell proliferation. This finding offers potential for hESC transplantation without immune rejection.

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Human embryonic stem cells (hESCs) hold promise for cell-based therapies.
  • Strategies to mitigate immune rejection of hESCs include MHC matching.
  • Experimental evaluation of immune responses to hESCs is lacking.

Purpose of the Study:

  • To investigate the immunogenicity of human embryonic stem cells (hESCs).
  • To determine if hESCs elicit an immune response in vivo and in vitro.
  • To explore the potential of hESCs to evade immune-mediated rejection.

Main Methods:

  • In vivo studies involving injection of hESCs into immune-competent mice.
  • In vitro assays assessing T-cell proliferation stimulated by undifferentiated and differentiated hESCs.

Related Experiment Videos

  • Co-culture experiments with allogeneic dendritic cells and T cells.

    • Main Results:

    • hESCs did not induce an immune response when injected into mice.
    • hESCs failed to stimulate alloreactive human T-cell proliferation.
    • hESCs inhibited dendritic cell-mediated T-cell proliferation through non-secreted mechanisms.
    • T cells previously exposed to hESCs did not proliferate upon re-exposure.

    Conclusions:

    • hESCs possess inherent immune-privileged characteristics.
    • These immune-evasive properties suggest potential for transplantation without immune rejection.
    • Further research into hESC immune privilege mechanisms is warranted.